Hemogenyx Pharmaceuticals Plc carries a market capitalization of 15.84M, placing it among publicly traded companies globally.
| Market Cap | 15.84M |
| Enterprise Value | N/A |
Hemogenyx Pharmaceuticals Plc's stock has gained approximately 87.90323% over the past 52 weeks. The 50-day moving average sits at 2.33, while the 200-day moving average is 2.33.
| Beta (5Y) | N/A |
| 52-Week Price Change | 87.90323% |
| 50-Day Moving Average | 2.33 |
| 200-Day Moving Average | 2.33 |
| Average Volume (20 Days) | N/A |
Hemogenyx Pharmaceuticals Plc's most recent stock split took place on December 13, 2024 with a 400:1 split ratio.
| Last Split Date | 12/13/2024 |
| Split Ratio | 400:1 |